1Utterback RA, Ojeman R, Malek J. Parenchymatous cerebel- lar degeneration with dilantin intoxication [J].Neuropathol Exp Neurol, 1958,17:516-519.
2Hammond EJ, Wilder BJ.Immunoflurescent evidence for a specific binding site for phenytoin in the cerebellum [J ].Epi- lepsia, 1983,24:269-274.
3Squier W, Hope PL, Linderbamr RH. Neocerebellar hypo- plasia in a neonate following intra-uterine exposure to anti- convulsants [ J ]. Dev Med Child Neurol, 1990,32:737-742.
6Trimble MR.On the use of tranquillisers in epilepsy [J].Epi- lepsia, 2002,43 (Suppl 2) :25-27.
二级参考文献12
1[1]Lou JS, Goldfarb L, McShane L, et al. Use of buspirone for treatment of cerebellar ataxia[ J]. Arch Neurol, 1995 ;52: 982-988
2[2]Hamon M, Fattaccini GM, Adrien J, et al. Alterations of central serotonin and dopopamine rumover in rats treated with ipsapirone and other 5hydroxytryptamine1A agonists with potential anxiolytic properties [ J ]. J Pharmacol Ther, 1988 ;246: 745-752
3[3]Trouillas P, Brudon F, Adeleine P. Improvement of cerebellar ataxia with laevorotatory from of 5-hydrotryptophan [ J ]. Aroh Neurol, 1988; 45: 12171222
4[4]Yadid G, Sotnik-Barkai I, Tornatore C, et al. Neurochemical alterations in the cerebellum of a murine model of Niemann-Pick type C disease[J].Brain Res, 1998;799:250-256
5[5]Reader TA, Ase AR, Le Marec N, et al. Differential of L-trytophan andbuspirone on biogenic amine contents and metabolism in Lurcher mice cerebellum[ J]. Neurosci Lett,2000;280:171-174
6[6]Trouillas P, Xie J , Adeleine P. Buspirone, a serotonergic 5-HT1A agonist, is active in cerebellar ataxia. A new fact in favor of the serotonergic theory of ataxia[ J]. Prog Brain Res, 1997; 114:589-599
7[7]Hinder BC, Mauk ME, Peroutka SJ, et al. Buspirone, 8-OH-DPAT and ipsapirone:effects on hippocampal cerebellar and sciatic fiber excitability [J]. Brain Res, 1988;461:1-9
8[8]Pisani A, Ross WN. Weak effect of neuromodulators on climbing fiberactivated[ Ca2+ ]i increases in rat cerebellar Ptrkinje neurons [ J ]. Brain Res, 1999;831:113-118
9[9]Wessel K, Hermsdorfer J, Deger K, et al. Double-blind crossover study with laevorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases[J]. Arch Neurol, 1995 ;52:451-455
10[10]Trouillas P, Xie J, Adeleine P, et al. Buspirone, a 5-hydroxytryptamine1A agonist,is active in cerebellar ataxia[ J]. Arch Neurol, 1997;54:749-752
7Hauser W A,Annegers J F,Kurland L T.Incidence of epilepsy and unprovoked seizures in Rochester,Minneso- ta:1935-1984[J].Epilepsia,1993,34(3):453-468.
8Kwan P,Schachter S C,Brodie M J.Drug-Resistant Ep- Uepay[J].N Engl J Med,2011,365(10):919-926.
9McNamara J O.Drugs effective in the therapy of the epi- lepsies.In:Hardman J G,Limberd L E,Gilman A G,eds.Goodman and Gilman ys pharmacological basis of therapeutics,IOth ed[M].New York:McGraw Hill,2001:521-547.
